Xermelo 250 mg, Filmtabletten - 90 Swissmedic Key 66374001 Registration Holder Future Health Pharma GmbH Name Xermelo 250 mg, Filmtabletten Date of registration 28.03.2018 Introduction of Sequence 28.03.2018 ATC-Classification Telotristat (A16AX15) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size 90 Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680663740012 Medication Code Synthetika Pharmacode Disponibility
Composition ethylis telotristatas 250 mg ut telotristati etipras 327.9 mg corresp. telotristatum 237.80 mg, lactosum 167.91 mg, hydroxypropylcellulosum, carmellosum natricum conexum, natrium 4.54 mg, magnesii stearas, silica colloidalis, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Ethylis Telotristatas 250 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum E 171 color. Hydroxypropylcellulosum Lactosum 167.91 mg Macrogol 3350 Magnesii Stearas Sodium 4.54 mg Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Silica Colloidalis Talcum
Source Data was imported : 02.09.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
